Individuals affected with PEX13-related ZSD presented heterogeneous clinical features, including hypotonia, developmental regression, hearing/vision impairment, progressive spasticity and brain leukodystrophy. The gene discussed is PEX13; the disease is peroxisome biogenesis disorder.